[64Cu-NOTA-8-Aoc-BBN(7-1 4)N H2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues.

Autor: Prasanphanich, Adam F., Nanda, Prasant K., Rold, Tammy L., Lixin Ma, Lewis, Michael R., Garrison, Jered C., Hoffman, Timothy J., Sieckman, Gary L., Figueroa, Said D., Smith, Charles J.
Předmět:
Zdroj: Proceedings of the National Academy of Sciences of the United States of America; 7/24/2007, Vol. 104 Issue 30, p12462-12467, 6p, 3 Diagrams, 1 Chart, 1 Graph
Abstrakt: Radiolabeled peptides hold promise as diagnostic/therapeutic targeting vectors for specific human cancers. We report the design and development of a targeting vector, [64Cu-NOTA-8-Aoc-BBN(7- 14)NH2] (NOTA = 1,4,7-triazacyclononane-1,4,7-triacetic acid, 8-Aoc = 8-aminooctanoic acid, and BBN = bombesin), having very high selectivity and affinity for the gastrin-releasing peptide receptor (GRPr). GRPr5 are expressed on a variety of human cancers, including breast, lung, pancreatic, and prostate, making this a viable approach toward site-directed localization or therapy of these human diseases. In this study, [NOTA-X-BBN(7-14)NH2J conjugates were synthesized, where X = a specific pharmacokinetic modifier. The 1C50 of [NOTA-8-Aoc-BBN(7-14)NH2] was determined by a competitive displacement cell-binding assay in PC-3 human prostate cancer cells using 125I-[Tyr4]-BBN as the displacement ligand. An IC50 of 3.1 ± 0.5 nM was obtained, demonstrating high binding affinity of [NOTA-8-Aoc-BBNJ for the GRPr. [64Cu-NOTA-X-BBN] conjugates were prepared by the reaction of 64CuCI2 with peptides in buffered aqueous solution. In vivo studies of [64Cu-NOTA-8-Aoc- BBN(7-14)NH2] in tumor-bearing PC-3 mouse models indicated very high affinity of conjugate for the GRPr. Uptake of conjugate in tumor was 3.58 ± 0.70% injected dose (ID) per g at 1 h postintravenous injection (p.1.). Minimal accumulation of radioactivity in liver tissue (1.58 ± 0.40% ID per g, 1 h p.i.) is indicative of rapid renal-urinary excretion and suggests very high in vivo kinetic stability of [64Cu-NOTA-8-Aoc-BBN(7-14)NH2] with little or no in vivo dissociation of MCu2+ from the NOTA chelator. Kidney accumulation at 1 h p.i. was 3.79 ± 1.09% ID per g. Molecular imaging studies in GRPr-expressing tumor models produced high-contrast, high-quality micro-positron-emission tomography images. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index